Viewing StudyNCT00516802



Ignite Creation Date: 2024-05-05 @ 6:38 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00516802
Status: COMPLETED
Last Update Posted: 2009-05-15
First Post: 2007-08-13

Brief Title: A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Melanoma Neoplasms
Keywords:
Name View
dacarbazine View
PolyADP ribose polymerases View